MARKET

MTP

MTP

Midatech Pharma
NASDAQ
1.860
-0.061
-3.20%
After Hours: 2.060 +0.2 +10.75% 16:14 09/30 EDT
OPEN
1.889
PREV CLOSE
1.921
HIGH
1.920
LOW
1.849
VOLUME
9.58K
TURNOVER
0
52 WEEK HIGH
9.55
52 WEEK LOW
1.849
MARKET CAP
7.33M
P/E (TTM)
-0.2245
1D
5D
1M
3M
1Y
5Y
Why NLS Pharmaceutics Shares Dipped Over 23%; Here Are 67 Biggest Movers From Yesterday
Gainers
Benzinga · 4d ago
VJET, MTP and EVAX among mid-day movers
Gainers: Avenue Therapeutics (ATXI) +165%. PaxMedi...
Seekingalpha · 4d ago
Why Bellerophon Therapeutics Shares Are Trading Higher By 24%, Here Are 44 Stocks Moving In Tuesday's Mid-Day Session
Gainers
Benzinga · 4d ago
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
 
Benzinga · 09/20 12:15
Why Aditxt Shares Dipped Over 58%; Here Are 82 Biggest Movers From Friday
Gainers Panbela Therapeutics, Inc. (NASDAQ: PBLA) shares jumped 53% to close at $0.58 on Friday.
Benzinga · 09/19 05:53
12 Health Care Stocks Moving In Friday's Intraday Session
 
Benzinga · 09/16 18:06
Why NCR Is Trading Lower By Around 23%, Here Are 42 Stocks Moving In Friday's Mid-Day Session
Gainers Kensington Capital Acquisition Corp. IV (NYSE: AMPX) jumped 35.4% to $13.54 after gaining 11% on Thursday.
Benzinga · 09/16 16:38
Midatech Pharma Announces A Ratio Change On Its American Depositary Receipts From 1 ADR-For-5 Ordinary shares To 1 ADR-For-25 Ordinary Shares; Ratio Change Is Expected To Be September 26
- Reuters 
Benzinga · 09/14 14:02
More
About MTP
Midatech Pharma plc is a United Kingdom-based drug delivery technology company. The Company is focused on improving the bio-delivery and biodistribution of medicines. The Company's technologies include Q-Sphera, MidaSolve and MidaCore. Q-Sphera technology focusses on long acting injectables using three-dimensional (3D) printing technology. MidaCore technology platform uses ultra-small gold nanoparticle (GNP) drug conjugates. MidaSolve Nano Inclusion technology solubilizes molecules that have minimal solubility at biological potential of Hydrogen (pH) extending available routes of administration, including direct-to-tumor delivery. It has a pipeline of approximately 10 earlier stage programmes, which includes MTD211 (Schizophrenia, MDD), MTD219 (Prophylaxis, transplant rejection), MTX223, MTX213, MTX214, MTX110 (Glioblastoma), MTX110 (Brain Cancer in Children (DIPG)), MTX110 (Medulloblastoma) and MTX114 (Psoriasis).

Webull offers kinds of Midatech Pharma PLC-ADR stock information, including NASDAQ:MTP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MTP stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading MTP stock methods without spending real money on the virtual paper trading platform.